103 related articles for article (PubMed ID: 8466217)
1. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.
Correia O; Delgado L; Ramos JP; Resende C; Torrinha JA
Arch Dermatol; 1993 Apr; 129(4):466-8. PubMed ID: 8466217
[TBL] [Abstract][Full Text] [Related]
2. Impaired antigen presentation in toxic epidermal necrolysis.
Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
[TBL] [Abstract][Full Text] [Related]
3. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
Friedmann PS; Strickland I; Pirmohamed M; Park BK
Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
Nassif A; Bensussan A; Boumsell L; Deniaud A; Moslehi H; Wolkenstein P; Bagot M; Roujeau JC
J Allergy Clin Immunol; 2004 Nov; 114(5):1209-15. PubMed ID: 15536433
[TBL] [Abstract][Full Text] [Related]
5. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
6. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
Miyauchi H; Hosokawa H; Akaeda T; Iba H; Asada Y
Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
[TBL] [Abstract][Full Text] [Related]
7. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
Mizukawa Y; Yamazaki Y; Shiohara T
Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
[TBL] [Abstract][Full Text] [Related]
8. Animal models of toxic epidermal necrolysis.
Azukizawa H
J Dermatol; 2011 Mar; 38(3):255-60. PubMed ID: 21342227
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
Merot Y; Gravallese E; Guillén FJ; Murphy GF
Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.
Paquet P; Nikkels A; Arrese JE; Vanderkelen A; Piérard GE
Arch Dermatol; 1994 May; 130(5):605-8. PubMed ID: 8179342
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
12. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
13. Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
Paquet P; De Groote D; Piérard GE
Dermatology; 2010; 220(3):201-7. PubMed ID: 20332596
[TBL] [Abstract][Full Text] [Related]
14. Selective migration of the human helper-inducer memory T cell subset: confirmation by in vivo cellular kinetic studies.
Pitzalis C; Kingsley GH; Covelli M; Meliconi R; Markey A; Panayi GS
Eur J Immunol; 1991 Feb; 21(2):369-76. PubMed ID: 1671837
[TBL] [Abstract][Full Text] [Related]
15. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].
Kopiński P
Folia Med Cracov; 1997; 38(3-4):69-115. PubMed ID: 10481384
[TBL] [Abstract][Full Text] [Related]
16. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin.
Mayorga C; Torres MJ; Corzo JL; Sanchez-Sabate E; Alvarez J; Vera A; Posadas S; Jurado A; Blanca M
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):86-91. PubMed ID: 12877456
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
18. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
Paquet P; Ribbens C; Piérard GE
Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
Baadsgaard O; Fox DA; Cooper KD
J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
